Kan Takagi

Statistics

Publications

Citations

H-Index

Active since

2010

Affiliations

Mitsubishi Tanabe Pharma Corporation(Current)

Kan Takagi is an author at Mitsubishi Tanabe Pharma Corporation specializing in pharmacology, sphingosine 1-phosphate receptor modulators, and receptor physiology.

Publications per year

2010–2018

Publications

Removal of Sphingosine 1-Phosphate Receptor-3 (S1P<sub>3</sub>) Agonism is Essential, But Inadequate to Obtain Immunomodulating 2-Aminopropane-1,3-diol S1P<sub>1</sub> Agonists with Reduced Effect on Heart Rate

Maiko Hamada, Mitsuharu Nakamura, Masatoshi Kiuchi et al. · Journal of Medicinal Chemistry · 2010 · 41 citations · Full text

Life Sciences, Biochemistry, Pharmacology +11

Comparison of electropharmacological effects between terfenadine and its active derivative fexofenadine using a cross-over study in halothane-anesthetized dogs to analyze variability of pharmacodynamic and pharmacokinetic profiles of terfenadine and torsadogenic risk of fexofenadine

Kentaro Ando, Yuji Nakamura, Mihoko Hagiwara-Nagasawa et al. · The Journal of Toxicological Sciences · 2018 · 11 citations · Full text

Veterinary Medicine, Pharmacokinetics, Pharmacology +10

1–2 of 2